Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
about
Early lung cancer detection by low-dose CT screening: therapeutic implications.Implementation of lung cancer CT screening in the Nordic countries.Selecting high-risk individuals for lung cancer screening; the use of risk prediction models vs. simplified eligibility criteria.Impact of noncardiac findings in patients undergoing CT coronary angiography: a substudy of the Scottish computed tomography of the heart (SCOT-HEART) trial.Lung cancer screening-low dose CT for lung cancer screening: recent trial results and next steps.Optimum low dose CT screening interval for lung cancer: the answer from NELSON?Lung Cancer Screening in the Post-National Lung Screening Trial Era: Applying Screening in the Real World.Solitary pulmonary ground-glass opacity: is it time for new surgical guidelines?A novel model uses metabolic and volumetric parameters to predict less invasive lung adenocarcinomas.Risk models to select high risk candidates for lung cancer screening.Screening for early stage lung cancer and its correlation with lung nodule detection.Evaluation of the 95% limits of agreement of the volumes of 5-year clinically stable solid nodules for the development of a follow-up system for indeterminate solid nodules in CT lung cancer screening.The narrow path to organized LDCT lung cancer screening programs in Europe
P2860
Q39049280-8DEC89F7-2F91-4D1E-BDEE-FAB8333E2BCBQ39344447-92AEB35A-CADF-490A-9389-76310E6357ABQ47097284-5B481D98-8CE4-4B42-93FC-D5E90C12995DQ47567231-36FED36B-EB02-41F6-9A88-A59952E5C3A1Q47819582-F14B02F5-0AA2-48B9-A09E-A9978617A070Q48019585-D747B7F3-DE23-4837-A1FE-D4BFF0C8274BQ48546834-E1938390-5602-482B-9271-C60FA1C410A9Q48580038-FEBD5355-A734-4D6F-85BB-1391C3F0F79CQ49821029-9229C053-669D-4043-A5F3-2006A4316FEAQ55078281-E1F8E516-0856-43C2-9A9F-5BDD73CA417BQ55154062-9174C18F-C60A-49BF-B2AD-61E765F7E8F9Q55279535-000B419D-6BB4-4B2A-8C44-F6BAB0CE1307Q57178576-A3EF418A-BA03-476E-BFA8-F66082EF6B11
P2860
Final screening round of the NELSON lung cancer screening trial: the effect of a 2.5-year screening interval.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Final screening round of the N ...... a 2.5-year screening interval.
@en
type
label
Final screening round of the N ...... a 2.5-year screening interval.
@en
prefLabel
Final screening round of the N ...... a 2.5-year screening interval.
@en
P2093
P50
P1433
P1476
Final screening round of the N ...... a 2.5-year screening interval.
@en
P2093
Carla Weenink
Carlijn van der Aalst
Harry Groen
Harry de Koning
Jan-Willem Lammers
Kristiaan Nackaerts
Marjolein Heuvelmans
Matthijs Oudkerk
Pim A de Jong
Rozemarijn Vliegenthart
P356
10.1136/THORAXJNL-2016-208655
P407
P577
2016-06-30T00:00:00Z